Boehringer Ingelheim Applauded by Frost & Sullivan for Continuing to Lead the Bio-CDMO Market With Its Cutting-edge Innovation
November 05, 2019
November 05, 2019
SAN ANTONIO, Texas, Nov. 5 -- Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services across multiple industries, issued the following news release:
Based on its recent analysis of the global biologics contract development and manufacturing organization (CDMO) market, Frost & Sullivan recognises the biopharmaceutical contract development and manufacturing business of Germany-headquartered Boehringer Ingelheim, op . . .
Based on its recent analysis of the global biologics contract development and manufacturing organization (CDMO) market, Frost & Sullivan recognises the biopharmaceutical contract development and manufacturing business of Germany-headquartered Boehringer Ingelheim, op . . .